Abstract
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Issue: Jul/Aug 2003 - After the Women's Health Initiative Trial
Page(s): 288-291
Download in electronic PDF format for $75
Abstract
This discussion of Raynaud’s disease focuses on etiology, pathophysiology, clinical manifestations, diagnosis, prognosis, treatment and recommendations. Tables provide information about drugs of choice for treating Raynaud’s disease and/or Raynaud’s phenomenon, nutritional supplements that may safely reduce the severity and frequency of attacks and sample formulations for treating Raynaud’s disease (Nifedipine in PLO Gel, Nitroglycerin 0.2% Ointment, Coenzyme Q10 100 mg-in-Oil Capsules and Zinc, Magnesium, Calcium and Vitamin D3 Oral Liquid).
Related Keywords
- Calcium, for the treatment of Raynaud's disease
- Coenzyme Q10, for the treatment of Raynaud's disease
- Coenzyme Q10 in oil capsules, for the treatment of Raynaud's disease
- Lecithin, for the treatment of Raynaud's disease
- Magnesium, for the treatment of Raynaud's disease
- Nifedipine in Pluronic lecithin organogel, for the treatment of Raynaud's disease
- Nitroglycerin 0.2% ointment, for the treatment of Raynaud's disease
- Nutritional supplements, for treatment of Raynaud's disease
- Raynaud's disease, compounding for
- Raynaud's phenomenon, treatment of
- Vitamin E, for the treatment of Raynaud's disease
- Zinc, for the treatment of Raynaud's disease
- Zinc, magnesium, calcium, and vitamin D3 oral liquid, for the treatment of Raynaud's disease
Related Categories
- DERMATOLOGY
- PAIN MANAGEMENT